Psychedelic Assisted Therapy in
Denver Colorado

In November, Coloradans embraced change by passing Proposition 122, paving the way for a groundbreaking shift in therapeutic services. The proposition not only decriminalizes the 'personal use' of psilocybin mushrooms but also sets the stage for legal psilocybin-assisted therapy in the state. While the latter won't kick in until 2024, the immediate impact of the former is felt, as individuals aged 21 and above can now possess, share, or gift psilocybin mushrooms without facing criminal charges.

This newfound legal landscape, however, comes with its own set of restrictions. Practitioners are prohibited from selling psilocybin-containing mushrooms and are barred from suggesting or recommending psilocybin use until the therapy gains full legal recognition.

​

The push for psilocybin-assisted therapy is rooted in recent research showcasing its potential benefits. Psilocybin, found in certain mushrooms, has been consumed for centuries, particularly by indigenous peoples in Mexico and Central America. The FDA's acknowledgment of psilocybin's effectiveness in treating treatment-resistant depression has sparked clinical trials at major research institutions like Johns Hopkins University, New York University, Harbor-UCLA School of Medicine, and the Heffter Research Institute.

​

Studies reveal promising outcomes, especially in addressing end-of-life anxiety and depression. Patients administered moderate doses of psilocybin experienced an immediate reduction in anxiety and depression, with a majority reporting sustained improvement even six months later. Notably, 70% considered the psilocybin session among the top five most meaningful experiences of their lives.

Despite these positive findings, it's crucial to acknowledge ongoing clinical trials exploring psilocybin's efficacy in treating conditions like treatment-resistant depression, end-of-life distress, OCD, cluster headaches, and various addictions. The evidence so far is compelling, but conclusive statements await the completion of thorough research.

​

Understanding the potential side effects is essential. While many report euphoria, unity with the universe, and positive perceptual changes, some individuals may experience discomfort, nausea, headaches, increased heart rate, body temperature, rapid breathing, vomiting, and facial flushes.

In Colorado, practitioners, bound by the current legal framework, are unable to sell psilocybin-containing mushrooms. However, they can offer valuable guidance on the safe and effective personal use of psilocybin, emphasizing patient safety and cultivating a meaningful practitioner-patient relationship.

Distinguishing conscientious providers is key. Some adopt a hands-off approach, offering a one-time session to explain psilocybin use, while others, like the Denver-based Integrative Psychotherapy, take a more comprehensive approach. Practitioners, such as Bianca Aarons, prioritize a transformative experience for the patient, integrating safety and self-exploration into the therapeutic journey.